![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
|
|
|
|
|
||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication June 6, 2007.
Revised July 10, 2007.
Accepted for publication July 10, 2007.
Glucocorticoids (corticosteroids) are highly effective in combating inflammation in the context of a variety of diseases. However, clinical utility can be compromised by the development of side effects, many of which are attributed to the ability of the glucocorticoid receptor (GR) to induce the transcription of, or transactivate, certain genes. By contrast the anti-inflammatory effects of glucocorticoids are to a very large extent due to their ability to reduce the expression of pro-inflammatory genes. This effect has been predominantly attributed to the repression of key inflammatory transcription factors, including AP-1 and NF-
B, and is termed transrepression. The ability to functionally separate these transcriptional functions of GR has prompted a search for dissociated GR ligands that can differentially induce transrepression, but not transactivation. In this review, we present evidence that post-transcriptional mechanisms of action are highly important to the anti-inflammatory actions of glucocorticoids. Furthermore, we present the case that mechanistically distinct forms of glucocorticoid-inducible gene expression are critical to the development of anti-inflammatory effects by repressing inflammatory signaling pathways and inflammatory gene expression at multiple levels. Considerable care is therefore required to avoid loss of anti-inflammatory effectiveness in the development of novel transactivation-defective ligands of GR.
Key words:
Glucorticoids/Mineralocorticoids, AP-1, NFkappaB
This article has been cited by other articles:
|
|
 |
|
  S. M. Wilson, P. Shen, C. F. Rider, S. L. Traves, D. Proud, R. Newton, and M. A. Giembycz Selective Prostacyclin Receptor Agonism Augments Glucocorticoid-Induced Gene Expression in Human Bronchial Epithelial Cells J. Immunol., November 15, 2009; 183(10): 6788 - 6799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Biggadike, R. K. Bledsoe, D. M. Coe, T. W. J. Cooper, D. House, M. A. Iannone, S. J. F. Macdonald, K. P. Madauss, I. M. McLay, T. J. Shipley, et al. Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor PNAS, October 27, 2009; 106(43): 18114 - 18119. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Muzikar, N. G. Nickols, and P. B. Dervan Repression of DNA-binding dependent glucocorticoid receptor-mediated gene expression PNAS, September 29, 2009; 106(39): 16598 - 16603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. King, N. S. Holden, W. Gong, C. F. Rider, and R. Newton Inhibition of NF-{kappa}B-dependent Transcription by MKP-1: TRANSCRIPTIONAL REPRESSION BY GLUCOCORTICOIDS OCCURRING VIA p38 MAPK J. Biol. Chem., September 25, 2009; 284(39): 26803 - 26815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. King, M. Kaur, W. Gong, C. F. Rider, N. S. Holden, and R. Newton Regulation of Tristetraprolin Expression by Interleukin-1{beta} and Dexamethasone in Human Pulmonary Epithelial Cells: Roles for Nuclear Factor-{kappa}B and p38 Mitogen-Activated Protein Kinase J. Pharmacol. Exp. Ther., August 1, 2009; 330(2): 575 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Bougarne, R. Paumelle, S. Caron, N. Hennuyer, R. Mansouri, P. Gervois, B. Staels, G. Haegeman, and K. De Bosscher PPAR{alpha} blocks glucocorticoid receptor {alpha}-mediated transactivation but cooperates with the activated glucocorticoid receptor {alpha} for transrepression on NF-{kappa}B PNAS, May 5, 2009; 106(18): 7397 - 7402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. De Bosscher and G. Haegeman Minireview: Latest Perspectives on Antiinflammatory Actions of Glucocorticoids Mol. Endocrinol., March 1, 2009; 23(3): 281 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Ye, Y. Nakamura, E. Lalli, and W. E. Rainey Differential Effects of High and Low Steroidogenic Factor-1 Expression on CYP11B2 Expression and Aldosterone Production in Adrenocortical Cells Endocrinology, March 1, 2009; 150(3): 1303 - 1309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. S. Rani, N. Elango, S.-s. Wang, K. Kobayashi, and R. Strong Identification of an Activator Protein-1-Like Sequence as the Glucocorticoid Response Element in the Rat Tyrosine Hydroxylase Gene Mol. Pharmacol., March 1, 2009; 75(3): 589 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Leroy, S. De Seigneux, V. Agassiz, U. Hasler, M.-E. Rafestin-Oblin, M. Vinciguerra, P.-Y. Martin, and E. Feraille Aldosterone Activates NF-{kappa}B in the Collecting Duct J. Am. Soc. Nephrol., January 1, 2009; 20(1): 131 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Clark, J. R. S. Martins, and C. R. Tchen Role of Dual Specificity Phosphatases in Biological Responses to Glucocorticoids J. Biol. Chem., September 19, 2008; 283(38): 25765 - 25769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. T. Ishmael, X. Fang, M. R. Galdiero, U. Atasoy, W. F. C. Rigby, M. Gorospe, C. Cheadle, and C. Stellato Role of the RNA-Binding Protein Tristetraprolin in Glucocorticoid-Mediated Gene Regulation J. Immunol., June 15, 2008; 180(12): 8342 - 8353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Saleh, T. S. Mann, T. Peters, R. J. Betts, and P. J. Henry Influence of Dexamethasone on Protease-Activated Receptor 2-Mediated Responses in the Airways J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 622 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kaur, J. E. Chivers, M. A. Giembycz, and R. Newton Long-Acting 2-Adrenoceptor Agonists Synergistically Enhance Glucocorticoid-Dependent Transcription in Human Airway Epithelial and Smooth Muscle Cells Mol. Pharmacol., January 1, 2008; 73(1): 203 - 214. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
